Meet Dr. Anne-Marie Baird. Passionate lung cancer researcher and advocate at Trinity College in Dublin. She's also President of Lung Cancer Europe.
Dave Bjork Dave Bjork

Meet Dr. Anne-Marie Baird. Passionate lung cancer researcher and advocate at Trinity College in Dublin. She's also President of Lung Cancer Europe.

On today's episode, meet Dr. Anne-Marie Baird. Dr. Baird is a lung cancer researcher at Trinity College in Dublin, Ireland. Her research interests are in inflammation, the metastatic cascade, drug resistance and disease biomarkers. She is active in lung cancer advocacy, and an avid supporter of The White Ribbon Project..

Read More
Meet Dr. Marc Matrana. Director of the Ochsner Precision Cancer Therapies Program, the only dedicated Phase I cancer research program between Houston and Birmingham.
Dave Bjork Dave Bjork

Meet Dr. Marc Matrana. Director of the Ochsner Precision Cancer Therapies Program, the only dedicated Phase I cancer research program between Houston and Birmingham.

On today's program, meet Dr. Marc Matrana, Director of the Precision Cancer Therapies (Phase I) Research Program, Endowed Professor of Experimental Therapeutics & Associate Director of Clinical Cancer Research, at the Ochsner Cancer Institute. Marc believes every cancer patient should be screened…

Read More
Meet Dr. Misako Nagasaka. Accomplished thoracic oncologist with unique experience and training in Japan and the United States. She's making a difference in the lives of her patients.
Dave Bjork Dave Bjork

Meet Dr. Misako Nagasaka. Accomplished thoracic oncologist with unique experience and training in Japan and the United States. She's making a difference in the lives of her patients.

On today's episode, meet Dr. Misako Nagasaka. Dr. Nagasaka is a board-certified thoracic oncologist at the University of California - Irvine who specializes in the diagnosis and treatment of lung and thyroid cancer. Her clinical interests also include early-phase clinical trials, medical ethics and survivorship care for patients…

Read More
Meet Hong Tang. Accomplished pharmaceutical industry executive. Passionate about diversity in clinical trials. Her calling is giving back, and it's personal for her.
Dave Bjork Dave Bjork

Meet Hong Tang. Accomplished pharmaceutical industry executive. Passionate about diversity in clinical trials. Her calling is giving back, and it's personal for her.

On today's episode, meet Hong Tang. Hong is Co- Lead of the PAN Asian Network Health Equity Initiative Team, and Executive Product Specialist in Immuno-Oncology at Bristol Myers Squibb. Hear her amazing story of her family leaving Vietnam just before the fall of Saigon and why her work in diversity and inclusion in oncology is personal…

Read More
Meet Rodney Gillespie, accomplished pharmaceutical industry executive. He is passionate about giving back to disadvantaged communities and kids.
Dave Bjork Dave Bjork

Meet Rodney Gillespie, accomplished pharmaceutical industry executive. He is passionate about giving back to disadvantaged communities and kids.

On today's episode, meet Rodney Gillespie. Rodney is a Global executive with broad leadership experience. He is currently the Vice President, Oncology Sales & Marketing, Solid Tumor at The Janssen Pharmaceutical Companies of Johnson & Johnson. He has a passion for participating in activities and organizations that allow him to give back to disadvantaged communities and kids…

Read More
Meet Dr. David Spigel, dedicated thoracic medical oncologist and Chief Scientific Officer at Sarah Cannon Research Institute. He's committed to bringing the latest innovative treatments to patients.
Dave Bjork Dave Bjork

Meet Dr. David Spigel, dedicated thoracic medical oncologist and Chief Scientific Officer at Sarah Cannon Research Institute. He's committed to bringing the latest innovative treatments to patients.

On today's episode, meet Dr. David Spigel. Dr. Spigel is the Chief Scientific Officer at Sarah Cannon Research Institute. He oversees all scientific aspects of Sarah Cannon's clinical trial program, working with the research physician leaders to ensure the best new agents and studies are available to their patients…

Read More